-
Good news: Recent research indicates that the human papillomavirus (HPV) vaccine Gardasil (Merck & Co.; Whitehouse Station, NJ) also provides about 40% cross-protection against other common oncogenic strains of HPV, in addition to its established strains.
-
-
When payday rolls around in your office, are envelopes met with grins or grimaces? For providers in family planning, 2007 proved to bring fewer smiles on the salary scene.
-
Intrauterine contraception is safe and effective, but many clinicians continue to exclude it from their list of contraceptive options.
-
Officials at the District of Columbia Department of Health (DOH) are retooling the city's condom distribution program after meeting public resistance to its customized condoms.
-
Your patients may be asking you about research news that indicates that use of oral contraceptives (OCs) increase cancer risk for women who use the method for more than eight years.
-
Progress toward an effective HIV vaccine has encountered a major roadblock with the cessation of a HIV vaccine clinical trial sponsored by Merck & Co. Meanwhile, the need for an effective vaccine continues to grow: The number of new infections in 2006 rose to 4.3 million around the globe, 400,000 more than in 2004.
-
-
-
Between 2000 and 2004 these French investigators studied 2863 women to determine the frequency of reported symptoms (weight gain, nausea, breast tenderness, swollen legs, fewer periods, breakthrough bleeding, painful/heavy periods) relative to the type of OCP taken (estrogen dose, progestin component, sequence of administration).